Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-03-07 02:49:08 UTC |
---|
HMDB ID | HMDB0001170 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Lathosterol |
---|
Description | Lathosterol is a a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. It is used as an indicator of whole-body cholesterol synthesis (PMID 14511438 ). Plasma lathosterol levels are significantly elevated in patients with bile acid malabsorption (PMID:8777839 ). Lathosterol oxidase (EC 1.14.21.6) is an enzyme that catalyzes the chemical reaction 5alpha-cholest-7-en-3beta-ol + NAD(P)H + H+ + O2 cholesta-5,7-dien-3beta-ol + NAD(P)+ + 2 H2O. |
---|
Structure | [H][C@@]1(CC[C@@]2([H])C3=CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h10,18-21,23-25,28H,6-9,11-17H2,1-5H3/t19-,20+,21+,23-,24+,25+,26+,27-/m1/s1 |
---|
Synonyms | Value | Source |
---|
gamma-Cholesterol | ChEBI | 5alpha-Cholest-7-en-3beta-ol | Kegg | g-Cholesterol | Generator | Γ-cholesterol | Generator | 5a-Cholest-7-en-3b-ol | Generator | 5Α-cholest-7-en-3β-ol | Generator | (3beta)-Cholest-7-en-3-ol | HMDB | (3beta,5alpha)-Cholest-7-en-3-ol | HMDB | (3beta,alpha)-Cholest-7-en-3-ol | HMDB | (7)-Cholestenol | HMDB | 3b-Hydroxy-5-cholestene | HMDB | 3beta-Hydroxy-5alpha-cholest-7-ene | HMDB | 5-a-Cholest-7-en-3-beta-ol | HMDB | 5-alpha-Cholest-7-en-3-beta-ol | HMDB | 7-Cholesten-3-beta-ol | HMDB | 7-Cholestenol | HMDB | 7-Cholesterol | HMDB | Cholest-7-en-3-ol | HMDB | Cholest-7-en-3beta-ol | HMDB | Cholest-7-en-ol | HMDB | Cholesterol - synthetic | HMDB | Cholesterol extra pure | HMDB | Cholesterol GR | HMDB | Cholesterol pharma | HMDB | Cholesterol,NF grade | HMDB | delta(7)-Cholestenol | HMDB | DELTA7-Cholesten-3beta-ol | HMDB | DELTA7-Cholestenol | HMDB | gamma-Cholestenol | HMDB | Lathosterol | ChEBI |
|
---|
Chemical Formula | C27H46O |
---|
Average Molecular Weight | 386.6535 |
---|
Monoisotopic Molecular Weight | 386.354866094 |
---|
IUPAC Name | (1R,2S,5S,7S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-ol |
---|
Traditional Name | (1R,2S,5S,7S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-ol |
---|
CAS Registry Number | 80-99-9 |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])C3=CC[C@@]4([H])C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C |
---|
InChI Identifier | InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h10,18-21,23-25,28H,6-9,11-17H2,1-5H3/t19-,20+,21+,23-,24+,25+,26+,27-/m1/s1 |
---|
InChI Key | IZVFFXVYBHFIHY-SKCNUYALSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Cholestane steroids |
---|
Direct Parent | Cholesterols and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Cholesterol-skeleton
- Cholesterol
- 3-beta-hydroxysteroid
- Hydroxysteroid
- 3-hydroxysteroid
- 3-hydroxy-delta-7-steroid
- Delta-7-steroid
- Cyclic alcohol
- Secondary alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organooxygen compound
- Alcohol
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 122.0 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lathosterol GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ab9-1019000000-45e8f26aff61be3d325a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lathosterol GC-MS (1 TMS) - 70eV, Positive | splash10-0006-3004900000-efe936a9ed1a83aa429c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Lathosterol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 10V, Positive-QTOF | splash10-014r-0009000000-88fe25051d65e99ecb32 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 20V, Positive-QTOF | splash10-05p9-3149000000-d25373f7179ed89b61dc | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 40V, Positive-QTOF | splash10-0c00-6359000000-8bff83f3efe22597deab | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 10V, Negative-QTOF | splash10-000i-0009000000-82b1527837d67c6be40a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 20V, Negative-QTOF | splash10-000i-0009000000-e2badd995ee41a69b18f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 40V, Negative-QTOF | splash10-0ldi-1009000000-96f6e67651380e1c959e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 10V, Positive-QTOF | splash10-000i-0009000000-178681247f5078239898 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 20V, Positive-QTOF | splash10-0avu-9233000000-247b9ee1da8d484a4da6 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 40V, Positive-QTOF | splash10-0a4l-9710000000-8ebbaf147cf1232af879 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 10V, Negative-QTOF | splash10-000i-0009000000-c037f2d2f217e99b79ac | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 20V, Negative-QTOF | splash10-000i-0009000000-c037f2d2f217e99b79ac | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lathosterol 40V, Negative-QTOF | splash10-001i-0009000000-fbd8e8ecfb898bb732a5 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Extracellular
- Membrane (predicted from logP)
- Endoplasmic reticulum
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adipose Tissue
- Adrenal Cortex
- Adrenal Gland
- Adrenal Medulla
- Bladder
- Brain
- Epidermis
- Eye Lens
- Fibroblasts
- Intestine
- Kidney
- Liver
- Neuron
- Ovary
- Pancreas
- Placenta
- Platelet
- Prostate
- Skeletal Muscle
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 9.9 +/- 7.0 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 5.38 +/- 0.038 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 2.43 +/- 0.048 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | <18 uM | Children (1-13 years old) | Male | Normal | | details | Blood | Detected and Quantified | <0.000129 uM | Newborn (0-30 days old) | Not Specified | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 67.5 +/- 58.4 uM | Adult (>18 years old) | Both | Cerebrotendinous xanthomatosis (CTX) | | details | Blood | Detected and Quantified | 9.6 (5.4-13.5) uM | Adult (>18 years old) | Female | Cirrhosis | | details | Blood | Detected and Quantified | 81.6 uM | Children (1-13 years old) | Male | Lathosterolosis | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Cerebrotendinous xanthomatosis |
---|
- Halperin G, Elisaf M, Leitersdorf E, Harats D: A new method for determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl. 2000 Jun 9;742(2):345-52. [PubMed:10901139 ]
| Cirrhosis |
---|
- Halperin G, Elisaf M, Leitersdorf E, Harats D: A new method for determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl. 2000 Jun 9;742(2):345-52. [PubMed:10901139 ]
| Lathosterolosis |
---|
- Ho AC, Fung CW, Siu TS, Ma OC, Lam CW, Tam S, Wong VC: Lathosterolosis: a disorder of cholesterol biosynthesis resembling smith-lemli-opitz syndrome. JIMD Rep. 2014;12:129-34. doi: 10.1007/8904_2013_255. Epub 2013 Oct 20. [PubMed:24142275 ]
| Colorectal cancer |
---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
Associated OMIM IDs | - 213700 (Cerebrotendinous xanthomatosis)
- 607330 (Lathosterolosis)
- 114500 (Colorectal cancer)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022463 |
---|
KNApSAcK ID | C00023744 |
---|
Chemspider ID | 59151 |
---|
KEGG Compound ID | C01189 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | 37036 |
---|
Wikipedia Link | Lathosterol |
---|
METLIN ID | 6052 |
---|
PubChem Compound | 65728 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 17168 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | LTHSTRL |
---|
MarkerDB ID | MDB00000305 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Fieser, Louis F. Cholesterol and companions. III. Cholestanol, lathosterol, and ketone 104. Journal of the American Chemical Society (1953), 75 4395-403. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Brunetti-Pierri N, Corso G, Rossi M, Ferrari P, Balli F, Rivasi F, Annunziata I, Ballabio A, Russo AD, Andria G, Parenti G: Lathosterolosis, a novel multiple-malformation/mental retardation syndrome due to deficiency of 3beta-hydroxysteroid-delta5-desaturase. Am J Hum Genet. 2002 Oct;71(4):952-8. Epub 2002 Aug 20. [PubMed:12189593 ]
- Nikkila K, Hockerstedt K, Miettinen TA: Liver transplantation modifies serum cholestanol, cholesterol precursor and plant sterol levels. Clin Chim Acta. 1992 Jun 30;208(3):205-18. [PubMed:1499139 ]
- Paiva H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, Laakso J, Lehtimaki T, von Bergmann K, Lutjohann D, Laaksonen R: High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. Clin Pharmacol Ther. 2005 Jul;78(1):60-8. [PubMed:16003294 ]
- Rioux FM, Innis SM: Cholesterol and fatty acid metabolism in piglets fed sow milk or infant formula with or without addition of cholesterol. Metabolism. 1993 Dec;42(12):1552-9. [PubMed:8246769 ]
- Laaksonen R, Thelen KM, Paiva H, Matinheikki J, Vesalainen R, Janatuinen T, Knuuti J, Rontu R, von Bergmann K, Lutjohann D, Lehtimaki T: Genetic variant of the SREBF-1 gene is significantly related to cholesterol synthesis in man. Atherosclerosis. 2006 Mar;185(1):206-9. Epub 2005 Jul 11. [PubMed:16005884 ]
- Lutjohann D, Harzer K, Gieselmann V, Eckhardt M: Reduced brain cholesterol content in arylsulfatase A-deficient mice. Biochem Biophys Res Commun. 2006 Jun 2;344(2):647-50. Epub 2006 Apr 7. [PubMed:16630546 ]
- Hamilton JJ, Synnes A, Innis SM: Plasma cholesterol and lathosterol levels in term infants in the early neonatal period. Pediatr Res. 1992 Apr;31(4 Pt 1):396-400. [PubMed:1570206 ]
- Boomsma DI, Princen HM, Frants RR, Gevers Leuven JA, Kempen HJ: Genetic analysis of indicators of cholesterol synthesis and absorption: lathosterol and phytosterols in Dutch twins and their parents. Twin Res. 2003 Aug;6(4):307-14. [PubMed:14511438 ]
- Farkkila MA, Kairemo KJ, Taavitsainen MJ, Strandberg TA, Miettinen TA: Plasma lathosterol as a screening test for bile acid malabsorption due to ileal resection: correlation with 75SeHCAT test and faecal bile acid excretion. Clin Sci (Lond). 1996 Apr;90(4):315-9. [PubMed:8777839 ]
|
---|